LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.82 | 17.25 | 1035 | 800 | 1.2929 | 1.0950 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.82 | 17.25 | 175 | 800 | 0.2186 | 0.5197 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.82 | 17.25 | 1263 | 800 | 1.5778 | 1.1717 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.79 | 17.25 | 561 | 1001 | 0.5601 | 0.8116 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.79 | 17.25 | 1058 | 1001 | 1.0563 | 1.0188 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.79 | 17.25 | 390 | 1001 | 0.3894 | 0.7026 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.79 | 17.25 | 1288 | 1001 | 1.2859 | 1.0877 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.76 | 17.25 | 812 | 1193 | 0.6803 | 0.8779 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.76 | 17.25 | 1064 | 1193 | 0.8914 | 0.9628 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.76 | 17.25 | 557 | 1193 | 0.4667 | 0.7656 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.76 | 17.25 | 1302 | 1193 | 1.0908 | 1.0287 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.73 | 17.25 | 932 | 1290 | 0.7224 | 0.8982 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.73 | 17.25 | 1088 | 1290 | 0.8433 | 0.9460 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.73 | 17.25 | 544 | 1290 | 0.4216 | 0.7409 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.73 | 17.25 | 1295 | 1290 | 1.0037 | 1.0012 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.70 | 17.25 | 1014 | 1466 | 0.6913 | 0.8881 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.70 | 17.25 | 1090 | 1466 | 0.7432 | 0.9095 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.70 | 17.25 | 662 | 1466 | 0.4514 | 0.7666 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.70 | 17.25 | 1303 | 1466 | 0.8884 | 0.9634 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.67 | 17.25 | 1036 | 1653 | 0.6267 | 0.8629 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.67 | 17.25 | 1101 | 1653 | 0.6660 | 0.8802 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.67 | 17.25 | 792 | 1653 | 0.4791 | 0.7885 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.67 | 17.25 | 1327 | 1653 | 0.8027 | 0.9343 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.64 | 17.25 | 1040 | 1887 | 0.5510 | 0.8315 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.64 | 17.25 | 1099 | 1887 | 0.5823 | 0.8465 | MN20160310_N02 | F03 |